Cargando…

A tamoxifen inducible knock-in allele for investigation of E2A function

BACKGROUND: E-proteins are transcription factors important for the development of a variety of cell types, including neural, muscle and lymphocytes of the immune system. E2A, the best characterized E-protein family member in mammals, has been shown to have stage specific roles in cell differentiatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Mary E, Kondo, Motonari, Zhuang, Yuan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765948/
https://www.ncbi.nlm.nih.gov/pubmed/19822014
http://dx.doi.org/10.1186/1471-213X-9-51
_version_ 1782173179030011904
author Jones, Mary E
Kondo, Motonari
Zhuang, Yuan
author_facet Jones, Mary E
Kondo, Motonari
Zhuang, Yuan
author_sort Jones, Mary E
collection PubMed
description BACKGROUND: E-proteins are transcription factors important for the development of a variety of cell types, including neural, muscle and lymphocytes of the immune system. E2A, the best characterized E-protein family member in mammals, has been shown to have stage specific roles in cell differentiation, lineage commitment, proliferation, and survival. However, due to the complexity of E2A function, it is often difficult to separate these roles using conventional genetic approaches. Here, we have developed a new genetic model for reversible control of E2A protein activity at physiological levels. This system was created by inserting a tamoxifen-responsive region of the estrogen receptor (ER) at the carboxyl end of the tcfe2a gene to generate E2AER fusion proteins. We have characterized and analyzed the efficiency and kinetics of this inducible E2A(ER )system in the context of B cell development. RESULTS: B cell development has been shown previously to be blocked at an early stage in E2A deficient animals. Our E2A(ER/ER )mice demonstrated this predicted block in B cell development, and E2AER DNA binding activity was not detected in the absence of ligand. In vitro studies verified rapid induction of E2AER DNA binding activity upon tamoxifen treatment. While tamoxifen treatment of E2A(ER/ER )mice showed inefficient rescue of B cell development in live animals, direct exposure of bone marrow cells to tamoxifen in an ex vivo culture was sufficient to rescue and support early B cell development from the pre-proB cell stage. CONCLUSION: The E2A(ER )system provides inducible and reversible regulation of E2A function at the protein level. Many previous studies have utilized over-expression systems to induce E2A function, which are complicated by the toxicity often resulting from high levels of E2A. The E2A(ER )model instead restores E2A activity at an endogenous level and in addition, allows for tight regulation of the timing of induction. These features make our E2A(ER )ex vivo culture system attractive to study both immediate and gradual downstream E2A-mediated events.
format Text
id pubmed-2765948
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27659482009-10-23 A tamoxifen inducible knock-in allele for investigation of E2A function Jones, Mary E Kondo, Motonari Zhuang, Yuan BMC Dev Biol Methodology Article BACKGROUND: E-proteins are transcription factors important for the development of a variety of cell types, including neural, muscle and lymphocytes of the immune system. E2A, the best characterized E-protein family member in mammals, has been shown to have stage specific roles in cell differentiation, lineage commitment, proliferation, and survival. However, due to the complexity of E2A function, it is often difficult to separate these roles using conventional genetic approaches. Here, we have developed a new genetic model for reversible control of E2A protein activity at physiological levels. This system was created by inserting a tamoxifen-responsive region of the estrogen receptor (ER) at the carboxyl end of the tcfe2a gene to generate E2AER fusion proteins. We have characterized and analyzed the efficiency and kinetics of this inducible E2A(ER )system in the context of B cell development. RESULTS: B cell development has been shown previously to be blocked at an early stage in E2A deficient animals. Our E2A(ER/ER )mice demonstrated this predicted block in B cell development, and E2AER DNA binding activity was not detected in the absence of ligand. In vitro studies verified rapid induction of E2AER DNA binding activity upon tamoxifen treatment. While tamoxifen treatment of E2A(ER/ER )mice showed inefficient rescue of B cell development in live animals, direct exposure of bone marrow cells to tamoxifen in an ex vivo culture was sufficient to rescue and support early B cell development from the pre-proB cell stage. CONCLUSION: The E2A(ER )system provides inducible and reversible regulation of E2A function at the protein level. Many previous studies have utilized over-expression systems to induce E2A function, which are complicated by the toxicity often resulting from high levels of E2A. The E2A(ER )model instead restores E2A activity at an endogenous level and in addition, allows for tight regulation of the timing of induction. These features make our E2A(ER )ex vivo culture system attractive to study both immediate and gradual downstream E2A-mediated events. BioMed Central 2009-10-12 /pmc/articles/PMC2765948/ /pubmed/19822014 http://dx.doi.org/10.1186/1471-213X-9-51 Text en Copyright © 2009 Jones et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology Article
Jones, Mary E
Kondo, Motonari
Zhuang, Yuan
A tamoxifen inducible knock-in allele for investigation of E2A function
title A tamoxifen inducible knock-in allele for investigation of E2A function
title_full A tamoxifen inducible knock-in allele for investigation of E2A function
title_fullStr A tamoxifen inducible knock-in allele for investigation of E2A function
title_full_unstemmed A tamoxifen inducible knock-in allele for investigation of E2A function
title_short A tamoxifen inducible knock-in allele for investigation of E2A function
title_sort tamoxifen inducible knock-in allele for investigation of e2a function
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2765948/
https://www.ncbi.nlm.nih.gov/pubmed/19822014
http://dx.doi.org/10.1186/1471-213X-9-51
work_keys_str_mv AT jonesmarye atamoxifeninducibleknockinalleleforinvestigationofe2afunction
AT kondomotonari atamoxifeninducibleknockinalleleforinvestigationofe2afunction
AT zhuangyuan atamoxifeninducibleknockinalleleforinvestigationofe2afunction
AT jonesmarye tamoxifeninducibleknockinalleleforinvestigationofe2afunction
AT kondomotonari tamoxifeninducibleknockinalleleforinvestigationofe2afunction
AT zhuangyuan tamoxifeninducibleknockinalleleforinvestigationofe2afunction